Pertussis, an acute respiratory tract infection caused by the bacterium
Bordetella pertussis, is among the most common vaccine-preventable childhood diseases in developed countries. It is characterized by spasms of coughing and a protracted course.
1 Although high immunization rates have lowered the number of pertussis cases substantially, widespread outbreaks still occur. Worldwide, an estimated 16 million cases occur each year.
2 Almost 50 000 pertussis cases were reported in the United States in 2012,
2,3 and an apparent resurgence of pertussis also has been recently reported in other countries.
3,4 The cause of this resurgence is unknown but may involve incomplete vaccination rates, use of acellular vaccines, and genetic changes in
B pertussis.
5 Infants younger than 2 months have the highest rates of pertussis-associated hospitalizations and deaths.
6 Although there is no evidence of neurotoxic effects of
B pertussis infections, increased intrathoracic and intra-abdominal pressure during coughing can result in central nervous system hemorrhages.
1 Together with hypoxemia, this may lead to encephalopathy,
7 occurring in 0.3% of infants with pertussis.
8